Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants.
Saved in:
| Title: | Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M |
|---|---|
| Authors: | Conley, Alexander C.1 (AUTHOR), Key, Alexandra P.1,2 (AUTHOR), Blackford, Jennifer U.1,3 (AUTHOR), Russell, Jason K.1,4 (AUTHOR), Albert, Kimberly M.1 (AUTHOR), Gong, Xuewen1 (AUTHOR), Bubser, Michael5,6 (AUTHOR), Rook, Jerri M.5,6 (AUTHOR), Conn, P. Jeffrey5,6 (AUTHOR), Lindsley, Craig W.5,6 (AUTHOR), Jones, Carrie K.5,6 (AUTHOR), Newhouse, Paul A.1 (AUTHOR) paul.newhouse@vanderbilt.edu |
| Source: | Alzheimer's Research & Therapy. 7/1/2025, Vol. 17 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17589193 |
|---|---|
| DOI: | 10.1186/s13195-025-01798-4 |
